Home Patheon Announces First Phase Of The UK Facility To Expand Early Development Capabilities In Europe
 

Keywords :   


Patheon Announces First Phase Of The UK Facility To Expand Early Development Capabilities In Europe

2013-02-11 09:49:03| drugdiscoveryonline Home Page

With the first phase of additional investment to Patheon’s Milton Park facility, the company will be able to expand upon the early development capabilities currently being offered, including the introduction of the SoluPath program.

Tags: development early europe expand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
More »